Sepsis in end-stage renal disease patients: are they at an increased risk of mortality?

被引:12
|
作者
Chebl, Ralphe Bou [1 ]
Tamim, Hani [1 ]
Abou Dagher, Gilbert [1 ]
Sadat, Musharaf [2 ,3 ,4 ]
Ghamdi, Ghassan [2 ,3 ,4 ]
Itani, Abdulrahman [2 ,3 ,4 ]
Saeedi, Alawi [2 ,3 ,4 ]
Arabi, Yaseen M. [2 ,3 ,4 ]
机构
[1] Amer Univ Beirut, Dept Emergency Med, Beirut, Lebanon
[2] Minist Natl Guard Hlth Affairs, Intens Care Dept, Riyadh, Saudi Arabia
[3] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
[4] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
关键词
ESRD; sepsis; intensive care; mortality; critical care; lengths of stay; GOAL-DIRECTED RESUSCITATION; SEPTIC SHOCK; INFECTIONS; UREMIA; ATHEROSCLEROSIS; INFLAMMATION; DEFINITIONS; OUTCOMES; DEFECTS; THERAPY;
D O I
10.1080/07853890.2021.1987511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aims to examine the outcome of end-stage renal disease (ESRD) patients admitted with sepsis to the intensive care unit (ICU). Design Single centre, retrospective cohort study Setting The study was conducted in the Intensive Care Department of King Abdulaziz Medical City, Riyadh, Saudi Arabia. Participants Data were extracted from a prospectively collected ICU database from 2002 to 2017. Patients were considered to have sepsis based on the sepsis-3 definition and were stratified into 2 groups based on the presence or absence of ESRD. Primary and secondary outcomes The primary outcome of the study was in-hospital mortality. Secondary outcomes included ICU mortality, ICU and hospital lengths of stay, and mechanical ventilation duration. Results A total of 8803 patients were admitted to the ICU with sepsis during the study period. 730 (8.3%) patients had ESRD. 49.04% of ESRD patients with sepsis died within their hospital stay vs. 31.78% of non-ESRD patients. ESRD septic patients had 1.44 greater odds of dying within their hospital stay as compared to septic non-ESRD patients (OR 1.44, 95% CI 1.03-1.53). Finally, the predictors of hospital mortality in septic ESRD patients were found to be mechanical ventilation (OR 3.36; 95% CI 2.27-5.00), a history of chronic liver disease (OR 2.26; 95% CI 1.26-4.07), and use of vasopressors (OR 1.74; 95% CI 1.19-2.54). Among patients with ESRD, hospital mortality was higher in subgroups of patients with chronic cardiac (OR 1.86 (1.36-2.53) vs. 1.19 (0.96-1.47)) and chronic respiratory illnesses (OR 2.20 (1.52-3.20) vs. 1.21 (0.99-1.48)). Conclusion ESRD patients admitted to the intensive care unit with sepsis are at greater odds of mortality compared to patients with non-ESRD. This risk is particularly increased if these patients have a concomitant history of chronic cardiac and respiratory illnesses. Key Messages Sepsis and bacterial infections are very common in ESRD patients and following cardiovascular disease; sepsis is the second leading cause of death in patients with ESRD. This study aims to examine the outcome of patients with end-stage renal disease (ESRD) patients admitted with sepsis to the intensive care unit (ICU). The results of this study have shown that end-stage renal disease is associated with greater odds of ICU and hospital mortality among septic patients admitted to an intensive care unit. ESRD patients were also more likely to be started on vasopressors and mechanical ventilation.
引用
收藏
页码:1737 / 1743
页数:7
相关论文
共 50 条
  • [41] Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients
    Asher, Deborah Rosenthal
    Halen, Nisha Ver
    Cukor, Daniel
    HEMODIALYSIS INTERNATIONAL, 2012, 16 (03) : 387 - 393
  • [42] SOCIAL SUPPORT AND SUBSEQUENT MORTALITY AMONG PATIENTS WITH END-STAGE RENAL-DISEASE
    MCCLELLAN, WM
    STANWYCK, DJ
    ANSON, CA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 4 (04): : 1028 - 1034
  • [43] The differential effects of anemia on mortality in young and elderly end-stage renal disease patients
    Ko, Eun Jeong
    Kim, Yong Kyun
    Cho, Jang-Hee
    Kim, Yon Su
    Kang, Shin-Wook
    Kim, Nam-Ho
    Kim, Yong-Lim
    Yang, Chul Woo
    Chung, Byung Ha
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2020, 39 (02) : 192 - 201
  • [44] Case-Fatality and Temporal Trends in Patients with Psoriasis and End-Stage Renal Disease
    Wild, Johannes
    Keller, Karsten
    Karbach, Susanne
    Weinmann-Menke, Julia
    Muenzel, Thomas
    Hobohm, Lukas
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [45] Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease An Analysis of the US Renal Data System
    Modi, Zubin J.
    Lu, Yee
    Ji, Nan
    Kapke, Alissa
    Selewski, David T.
    Dietrich, Xue
    Abbott, Kevin
    Nallamothu, Brahmajee K.
    Schaubel, Douglas E.
    Saran, Rajiv
    Gipson, Debbie S.
    JAMA CARDIOLOGY, 2019, 4 (04) : 353 - 362
  • [46] Periodontal disease adversely affects the survival of patients with end-stage renal disease
    Kshirsagar, Abhijit V.
    Craig, Ronald G.
    Moss, Kevin L.
    Beck, James D.
    Offenbacher, Steven
    Kotanko, Peter
    Klemmer, Philip J.
    Yoshino, Maki
    Levin, Nathan W.
    Yip, Julie K.
    Almas, Khalid
    Lupovici, Eva M.
    Usvyat, Len A.
    Falk, Ronald J.
    KIDNEY INTERNATIONAL, 2009, 75 (07) : 746 - 751
  • [47] Phosphorus and mortality risk in end-stage renal disease: A meta-analysis
    Hou, Yue
    Li, Xiujiang
    Sun, Liguang
    Qu, Zhihui
    Jiang, Lili
    Du, Yujun
    CLINICA CHIMICA ACTA, 2017, 474 : 108 - 113
  • [48] Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
    Carrero, Juan Jesus
    Grams, Morgan E.
    Sang, Yingying
    Arnlov, Johan
    Gasparini, Alessandro
    Matsushita, Kunihiro
    Qureshi, Abdul R.
    Evans, Marie
    Barany, Peter
    Lindholm, Bengt
    Ballew, Shoshana H.
    Levey, Andrew S.
    Gansevoort, Ron T.
    Elinder, Carl G.
    Coresh, Josef
    KIDNEY INTERNATIONAL, 2017, 91 (01) : 244 - 251
  • [49] Hypocalcemia, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Hu, LQ
    ODea, R
    Murray, DC
    Barre, PE
    AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (05) : 386 - 393
  • [50] Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
    Dieter, Brad P.
    McPherson, Sterling M.
    Afkarian, Maryam
    de Boer, Ian H.
    Mehrotra, Rajnish
    Short, Robert
    Barbosa-Leiker, Celestina
    Alicic, Radica Z.
    Meek, Rick L.
    Tuttle, Katherine R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (08) : 1467 - 1472